pursuant to which Mr. Akhavan will continue to serve as the President and Chief Executive Officer of EchoStar and will serve as a member of the Company Board upon the Effective Time
Appointed
Hamid Akhavan
President and Chief Executive Officer
DISH Network CORP
Filed
October 3, 2023, 7:59 PM ET
the DISH Board had approved the appointment of Mr. Hamid Akhavan as President and Chief Executive Officer of DISH and a member of the DISH Board, effective as of the date on which the Effective Time occurs
On October 2, 2023, the Company’s Board of Directors appointed Anthony D. Harnett to serve as Interim Chief Financial Officer of the Company, effective November 4, 2023.
Departed
Mark A. Wilcox
Executive Vice President and Chief Financial Officer
On September 28, 2023, Mark A. Wilcox, Executive Vice President and Chief Financial Officer of Selective Insurance Group, Inc. (the “Company”), notified the Company that he has resigned from his position to pursue a different opportunity, effective November 3, 2023.
Departed
(interim)
Wayde McMillan
Executive Vice President, Chief Financial Officer and Treasurer
On September 29, 2023, Wayde McMillan, the Executive Vice President, Chief Financial Officer and Treasurer of Insulet Corporation (the “ Company ”) informed the Company of his decision to resign from such position, effective October 20, 2023.
The Company’s Chief Accounting Officer and Controller, Lauren Budden, 48, will serve as Interim Chief Financial Officer (“ CFO ”) and Treasurer, effective upon Mr. McMillan’s departure.
Appointed
Colin Shannon
Chief Executive Officer
Syneos Health, Inc.
Effective
2023-10-03
Filed
October 3, 2023, 7:59 PM ET
Colin Shannon has been appointed Chief Executive Officer of the Company, effective immediately.
Role change
Michelle Keefe
Chief Executive Officer
Syneos Health, Inc.
Effective
2023-10-03
Successor
Colin Shannon
Filed
October 3, 2023, 7:59 PM ET
Mr. Shannon succeeds Michelle Keefe, who will continue her tenure with the Company as a key member of the Executive Leadership Team.
Appointed
Joel T. Grade
Executive Vice President and Chief Financial Officer
On September 29, 2023, Baxter International Inc. (the “Company”) appointed Mr. Joel T. Grade as its Executive Vice President and Chief Financial Officer, effective as of October 18, 2023.
Role change
Molly S. Beerman
Executive Vice President and Chief Financial Officer
Ms. Molly S. Beerman, the Company’s current Executive Vice President and Chief Financial Officer, will continue in her roles as the Company’s Executive Vice President and Chief Financial Officer but will cease to serve as the Company’s principal accounting officer effective as of the Effective Date.
Appointed
Brian Hungerford
Chief Financial Officer
Kiromic Biopharma, Inc.
Effective
2023-10-01
Filed
October 3, 2023, 7:59 PM ET
On October 1, 2023, Kiromic Biopharma, Inc. (the “Company”) entered into an executive employment agreement (the “Agreement”) with Brian Hungerford pursuant to which Mr. Hungerford will be employed by the Company as Chief Financial Officer.
On September 27, 2023, Kartoon Studios, Inc. (the “Company”) appointed Brian Parisi, age 53, as the Chief Financial Officer of the Company, effective September 27, 2023.
Departed
Ann P. Kelly
Executive Vice President and Chief Financial Officer
On October 2, 2023, the Company announced that, effective September 29, 2023, Ann P. Kelly’s employment was terminated as Executive Vice President and Chief Financial Officer.
Appointed
Charles E. Zebula
Executive Vice President and Chief Financial Officer
On September 29, 2023, the Board of Directors of American Electric Power Company Inc. (“AEP” or “Company”) elected Charles E. Zebula to serve as AEP’s Executive Vice President and Chief Financial Officer effective as of September 30, 2023.
(b) As of September 29, 2023, Mr. Mark Bilancieri was appointed principal financial officer of the General Partner for purposes of the management of the Fund.
As of September 29, 2023, Mr. Christopher Guarnotta, acting as the principal financial officer of the General Partner for purposes of the management of the Fund, resigned from the General Partner.
Marc Lautenbach will step down from his position as President and Chief Executive Officer and as a member of the Board, effective as of the Transition Date.
the Board appointed Jason C. Dies, Executive Vice President and Group Executive of the Company, to the position of Interim Chief Executive Officer of the Company effective October 2, 2023
Departed
(interim)
Howard Bernstein
Interim Chief Executive Officer
SQZ Biotechnologies Co
Effective
2023-11-15
Filed
October 2, 2023, 7:59 PM ET
the Company and each of Howard Bernstein, Ph.D., Interim Chief Executive Officer of the Company, Richard Capasso, Chief Accounting Officer of the Company, Marshelle Smith Warren, M.D., Chief Medical Officer of the Company, and Lawrence Knopf, General Counsel of the Company (collectively, the “Executive Officers”) entered into a transition agreement amending the terms of the Executive Officer’s employment agreement with the Company. The transition agreements provide for an agreed employment termination date for the Executive Officers of November 15, 2023
Appointed
Amir Ayalon
Chief Financial Officer
Tingo Group, Inc.
Effective
2023-10-02
Filed
October 2, 2023, 7:59 PM ET
Also on October 2, 2023, the Board of Directors appointed Amir Ayalon as the Company’s Chief Financial Officer.
On September 26, 2023, Bluejay Diagnostics, Inc. (the “Company”) and Kenneth R. Fisher agreed that Mr. Fisher would depart the Company as an employee and cease serving as its Chief Financial Officer (“CFO”).
On September 26, 2023, the Board of Directors (the “Board”) of the Company appointed Frances Scally, age 56, as interim CFO of the Company and designated her as the Company’s principal financial officer and principal accounting officer, effective immediately.
Departed
John Krier
Chief Executive Officer
DYNATRONICS CORP
Effective
2023-10-01
Successor
Brian D. Baker
Filed
October 2, 2023, 7:59 PM ET
John Krier's resignation as Chief Executive Officer and as a member of its Board of Directors
Role change
Brian D. Baker
Chief Executive Officer
DYNATRONICS CORP
Effective
2023-10-01
Filed
October 2, 2023, 7:59 PM ET
Brian D. Baker's (i) appointment as the Company's Chief Executive Officer and as a member of the Board, to fill the vacancies created by Mr. Krier's resignation from such positions, and (ii) resignation as the Company's Chief Operating Officer
Christopher Del Moral-Niles is joining the Company to serve as Executive Vice President and Chief Financial Officer of the Company and East West Bank (the “Bank”), effective as of October 2, 2023.
On October 2, 2023, V2X, Inc. (the “Company”) announced the appointment of Mr. Shawn Mural, age 53, as its new Senior Vice President and Chief Financial Officer to replace Ms. Susan D. Lynch, who retired from the Company on September 28, 2023.
On October 2, 2023, V2X, Inc. (the “Company”) announced the appointment of Mr. Shawn Mural, age 53, as its new Senior Vice President and Chief Financial Officer to replace Ms. Susan D. Lynch, who retired from the Company on September 28, 2023.
Appointed
(interim)
Patrick M. Shanahan
interim President and Chief Executive Officer
Spirit AeroSystems Holdings, Inc.
Effective
2023-09-30
Filed
October 2, 2023, 7:59 PM ET
On September 30, 2023, the Board appointed Patrick M. Shanahan as interim President and Chief Executive Officer of the Company and of the Employer.
Departed
(interim)
Thomas C. Gentile III
President and Chief Executive Officer
Spirit AeroSystems Holdings, Inc.
Effective
2023-09-30
Successor
Patrick M. Shanahan
Filed
October 2, 2023, 7:59 PM ET
Effective as of September 30, 2023 (the “Separation Date”), Thomas C. Gentile III ceased to serve as the President and Chief Executive Officer of Spirit AeroSystems Holdings, Inc. (the “Company”) and as a member of the Board of Directors (the “Board”) of the Company.
On October 2, 2023, the Board appointed Orit Mizrachi, the Company’s Chief Operating Officer, as interim Chief Financial Officer of the Company effective October 2, 2023.
On October 2, 2023, Venugopal Rathi notified the Board of Directors (the “Board”) of Morgan Stanley Direct Lending Fund (the “Company”) of his resignation as the Company’s Chief Financial Officer in order to pursue other professional opportunities.
Appointed
Thomas J. Leonard
Chief Executive Officer
AGILITI, INC. \DE
Effective
2023-10-01
Filed
October 2, 2023, 7:59 PM ET
appointed Thomas J. Leonard as Chief Executive Officer effective as of October 1, 2023
Departed
Thomas W. Boehning
Chief Executive Officer
AGILITI, INC. \DE
Effective
2023-09-28
Successor
Thomas J. Leonard
Filed
October 2, 2023, 7:59 PM ET
terminated Thomas W. Boehning’s employment as Chief Executive Officer without cause.
the Board of Directors (the “ Board ”) of Aadi Bioscience, Inc. (the “ Company ”) appointed David J. Lennon, Ph.D., to serve as the Company’s President and Chief Executive Officer and principal executive officer, effective as of October 2, 2023
Mr. Giacobello has served as the Company’s Interim CEO and President and principal executive officer since March 15, 2023, and will continue to serve as the Company’s Chief Financial Officer, a position he has held since November 2021, following Dr. Lennon’s appointment.
Departed
Nancy Simonian
President and Chief Executive Officer
Syros Pharmaceuticals, Inc.
Effective
2023-12-01
Successor
Conley Chee
Filed
October 2, 2023, 7:59 PM ET
On September 28, 2023, Nancy Simonian, M.D., the President and Chief Executive Officer of the Company, provided the Company with notice of her desire and intention to retire, and on October 2, 2023, the Company announced Dr. Simonian’s retirement effective as of December 1, 2023
Appointed
Conley Chee
President and Chief Executive Officer
Syros Pharmaceuticals, Inc.
Effective
2023-12-02
Filed
October 2, 2023, 7:59 PM ET
On October 2, 2023, the Company also announced that Conley Chee, currently the Company’s Chief Commercial Officer and Chief Business Officer, has been appointed by the Board of Directors to serve as the Company’s President and Chief Executive Officer effective as of December 2, 2023.
Appointed
Gary Pilnick
Chief Executive Officer
WK Kellogg Co
Effective
2023-10-02
Filed
October 2, 2023, 7:59 PM ET
effective as of the consummation of the Distribution, Gary Pilnick was appointed to serve as the Chief Executive Officer of WK Kellogg
On October 2, 2023, the Company announced the appointment of Carol Hibbard as Chief Financial Officer and Treasurer of the Company effective December 15, 2023.
On October 2, 2023, Symbotic Inc. (the “Company”) announced that Thomas Ernst plans to retire as Chief Financial Officer and Treasurer of the Company, with his retirement to be effective on December 15, 2023.
Effective as of October 13, 2023, Mr. Graham A. Fleming, 54, the Company’s current Chief Executive Officer (principal executive officer), will serve as interim Chief Financial Officer
Mr. Johan Gericke, the Chief Financial Officer of Finance of America Companies Inc. (the “Company”), notified the Company of his resignation, effective as of October 13, 2023.
On September 29, 2023, Mr. David Bryan Norwood provided notice to Perma-Pipe International Holdings, Inc. (the “Company”) of his intent to retire as the Company’s Vice President and Chief Financial Officer, Secretary and Treasurer effective October 2, 2023.
On October 2, 2023, the Company appointed Matthew Lewicki, age 41, as Vice President and Chief Financial Officer, Secretary and Treasurer of the Company.
Appointed
Tim Conder
Chief Executive Officer
TILT Holdings Inc.
Effective
2023-09-26
Filed
October 2, 2023, 7:59 PM ET
On September 26, 2023, the Board appointed Mr. Conder as the permanent Chief Executive Officer of the Company.
Appointed
Rick Dillon
Executive Vice President and Chief Financial Officer
Rick Dillon Executive Vice President and Chief Financial Officer
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.